Pharmacy Law

Marcus & Shapira has extensive experience representing pharmacies and pharmacists in a wide array of legal matters, ranging from bet-the-company litigation to negotiating complex agreements.

Our litigators have been heavily involved in the national opioid litigation and successfully defended a large regional pharmacy chain in all phases of litigation related to a national bellwether opioid case that proceeded to trial in 2021. Marcus & Shapira has also defended a variety of claims for pharmacist malpractice and whistle-blower actions.

The firm’s litigation team has also litigated complex pay-for-delay pharmacy antitrust claims against pharmaceutical manufacturers, working with expert witnesses to offer evidence on the complicated process of developing and launching brand and generic drugs with FDA approval.

Marcus & Shapira attorneys have also successfully negotiated complex primary vendor agreements worth over $1 billion in annual sales, as well as secondary supplier agreements and agreements for veterinary medicines. Our attorneys have given advice on the structure and operation of group purchasing organizations for the procurement of generic drugs at competitive prices. Our attorneys have also counseled on the issue of the creation and operation of a suspicious order monitoring system, in compliance with DEA requirements.